NEIMETH — NEIMETH INTERNATIONAL PHARMACEUTICALS Disclosures
2 filings on the Nigerian Exchange Group.
NEIMETH INTERNATIONAL PHARMACEUTICALS (NEIMETH) is listed on the Nigerian Exchange Group (NGX). This page tracks every regulatory disclosure NEIMETH INTERNATIONAL PHARMACEUTICALS has filed with the exchange — covering corporate actions and AGM notices — with plain-English summaries and direct links to each official PDF. The most recent filing was on 29 Jun 2026, and the records here go back to 18 Jun 2026. NEIMETH INTERNATIONAL PHARMACEUTICALS has a market capitalisation of about ₦35.25B and currently carries a HOLD signal on Aboki Forex's fundamental model.
NEIMETH Stock Snapshot
HOLD · 51.5/100Market Cap
₦35.25B
P/E Ratio
35.80
EPS (₦)
0.23
ROE %
36.03
Div Yield %
—
P/B Ratio
12.90
Latest NEIMETH filings
Corporate Action 29 Jun 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC-AGM RESOLUTIONS
* Shareholders approved the formal receipt of the 2025 audited financial statements, the appointment/re-election of directors, and the election of the Statutory Audit Committee members.
* Shareholders approved a new authorization for the Board to raise up to ₦30 billion in additional capital, bringing the total aggregate capital raising approval to ₦50 billion.
* The Board is authorized to raise these funds through various instruments, including shares (public offering, rights issue, or private placement), commercial papers, and bonds, and has secured an agreement to underwrite public offerings and rights issues.
📄 View PDF
AGM Notice 18 Jun 2026
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC - NOTICE OF ANNUAL GENERAL MEETING (AGM)
* Neimeth International Pharmaceuticals Plc. will hold its 67th Annual General Meeting virtually on June 25, 2026, at 11:00 am.
* Shareholders will be asked to approve an additional capital raise of ₦30,000,000,000, bringing the company's total authorized capital raising approval to ₦50,000,000,000, following an initial ₦20,000,000,000 authorization in 2025.
* The meeting will include the ratification of a new director, the re-election of three directors retiring by rotation, and the appointment of members to the Statutory Audit Committee.
📄 View PDF
What these NEIMETH disclosures mean
Corporate Action
Events such as dividend declarations, bonus issues, rights issues, share splits or mergers that directly affect NEIMETH shareholders' holdings.
AGM Notice
Formal notice of NEIMETH INTERNATIONAL PHARMACEUTICALS's Annual General Meeting, where shareholders vote on dividends, the re-election of directors, auditor appointments and other resolutions.
NEIMETH disclosures — frequently asked questions
NEIMETH INTERNATIONAL PHARMACEUTICALS has 2 recent disclosures on record on the Nigerian Exchange Group, covering corporate actions and AGM notices. The most recent was filed on 29 Jun 2026. Each filing on this page links to the official PDF on the NGX document library.
Every NEIMETH disclosure on this page links directly to the official PDF published on the Nigerian Exchange (NGX) document library. You can also get push notifications the moment NEIMETH INTERNATIONAL PHARMACEUTICALS files a new disclosure by using the Aboki Forex app.
Based on Aboki Forex's fundamental model, NEIMETH currently carries a HOLD signal with a fundamental score of 51.5/100, a P/E ratio of 35.80 and a return on equity of 36.03%. This is not investment advice — review the full fundamentals and the latest disclosures before deciding.
NEIMETH INTERNATIONAL PHARMACEUTICALS (NEIMETH) has a market capitalisation of approximately ₦35.25B on the Nigerian Exchange Group.
NGX-listed companies like NEIMETH INTERNATIONAL PHARMACEUTICALS file disclosures whenever there is a material event — typically quarterly and annual financial results, plus board meetings, AGM notices, dividend declarations and director dealings as they happen. This page is rebuilt regularly so the latest NEIMETH filings always appear at the top.